January 17, 2018 / 12:51 PM / a month ago

BRIEF-Curis Announces Initiation Of Phase 1 Trial Of CA-4948

Jan 17 (Reuters) - Curis Inc:

* CURIS ANNOUNCES INITIATION OF PHASE 1 TRIAL OF CA-4948, A SMALL MOLECULE INHIBITOR OF IRAK4 KINASE IN PATIENTS WITH LYMPHOMA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below